Skip to main content

Parallel or Crossover Designs in Evaluation of Antiarrhythmic Therapy

  • Chapter
The Evaluation of New Antiarrhythmic Drugs

Part of the book series: Developments in Cardiovascular Medicine ((DICM,volume 11))

Abstract

The crucial considerations in selecting a research design to test drug efficacy include:

  1. 1.

    Validity: If the drug is not effective, is the chance of a false positive finding less than 5% or 1%?

  2. 2.

    Power Efficiency: If the drug is effective, is the chance of a true positive finding reasonably high?

  3. 3.

    Feasibility and Cost: Can the design be reasonably implemented in the research situation for which it is proposed?

  4. 4.

    Clinical Value: Does the design yield information sufficient in extent and quality to serve as a basis for evaluation of the clinical value of the drug?

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Brown, W.B., Jr. The cross-over experiment for clinical trials. Biometrics, 1980, 36, 69–79.

    Article  PubMed  Google Scholar 

  2. Cohen, J. Statistical Power Analysis for the Behavioral Sciences. New York: Academic Press, 1969.

    Google Scholar 

  3. Kraemer, H.C. A central t approximation to the noncentral t distribution. Technometrics, 1979, 21(3) , 357–360.

    Article  Google Scholar 

  4. Morganroth, J., Michelson, E.L., Horowitz, L.N., Josephson, M.E., Pearlman, A.S., and Dunkman, W.B. Limitations of routine long-term electrocardiographic monitoring to assess ventricular ectopic frequency. Circulation, 1978, 58(3), 408–414.

    PubMed  CAS  Google Scholar 

  5. Sami, M., DeBusk, R.F., Harrison, D.C., Houston, N. and Shemasaki, C. A new method for evaluating antiarrhythmic drug efficacy in individual patients. Circulation, in press.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1981 Martinus Nijhojf Publishers bv, The Hague.

About this chapter

Cite this chapter

Kraemer, H.C. (1981). Parallel or Crossover Designs in Evaluation of Antiarrhythmic Therapy. In: Morganroth, J., Moore, E.N., Dreifus, L.S., Michelson, E.L. (eds) The Evaluation of New Antiarrhythmic Drugs. Developments in Cardiovascular Medicine, vol 11. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-8270-3_13

Download citation

  • DOI: https://doi.org/10.1007/978-94-009-8270-3_13

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-009-8272-7

  • Online ISBN: 978-94-009-8270-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics